Disease modeling and imaging assays using human iPS cell-derived airway organoids
Respiratory diseases include a wide range of conditions, including
chronic progressive diseases and acute and severe diseases such as
the recent COVID-19 pneumonia. However, the development of
fundamental therapeutics in this field has been slow, partly because
animal models such as mice used for preclinical drug efficacy evaluation
often do not reflect human disease states. A typical example is
cystic fibrosis (CF), an autosomal recessive genetic disorder caused
by mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR), a chloride ion channel.